Eli Lilly

Eli Lilly Preps Rejected Rheumatoid Arthritis Drug for Resubmission
Xconomy
Wed, 08/30/17 - 11:12 am
Eli Lilly
rheumatoid arthritis
FDA
baricitinib
Pharma Stocks That Could Move On New Data
Barron's
Sat, 08/26/17 - 07:36 pm
pharma stocks
AbbVie
Bayer
Novartis
Bristol-Myers Squibb
Eli Lilly
European Society of Cardiology
Diabetes drugs must prove their value to payers, analysts say
Medical Marketing and Media
Tue, 08/22/17 - 06:48 pm
diabetes
payers
Novo Nordisk
semaglutide
Eli Lilly
Trulicity
3 Most Promising Cancer Drugs in Late-Stage Development
Motley Fool
Tue, 08/22/17 - 10:04 am
Eli Lilly
abemaciclib
advanced breast cancer
Incyte
epacadostat
Imbruvica
JNJ
prostate cancer
Eli Lilly: Can Sales Grow Without M&A?
Barron's
Sat, 08/19/17 - 10:31 am
Eli Lilly
M&A
Eli Lilly’s odyssey to use a fake rule and fake news to protect bad patents
Stat
Wed, 08/16/17 - 11:11 am
Eli Lilly
patents
Canada
NAFTA
Strattera
Zyprexa
The 2017 report card so far: Big Biotech largely trading up as pharma posts mixed results
Fierce Pharma
Thu, 08/10/17 - 06:58 pm
pharma stocks
Merck
Pfizer
AbbVie
Eli Lilly
Bristol-Myers Squibb
GSK
Roche
Sanofi
Bayer
Novo Nordisk
Celgene
Biogen
AstraZeneca
Lilly's turn to pain gathers momentum
BioPharma Dive
Mon, 08/7/17 - 11:30 am
Eli Lilly
Lasmiditan
migraines
Lilly's acute migraine drug succeeds in late-stage study
Yahoo/Reuters
Fri, 08/4/17 - 11:35 am
Eli Lilly
migraines
clinical trials
Lasmiditan
CVS formulary knocks Lilly, BI's Jardiance in favor of J&J's Invokana
Fierce Pharma
Wed, 08/2/17 - 11:57 am
formulary
Eli Lilly
Boehringer Ingelheim
JNJ
Invokana
diabetes
CVS Caremark
Radius' Tymlos gets another big break as Express Scripts boots Lilly's Forteo
Fierce Pharma
Tue, 08/1/17 - 11:49 am
Radius Health
Tymlos
Express Scripts
PBMs
formulary
Eli Lilly
Forteo
osteoporosis
Eli Lilly CEO expects a Trump executive order on drug pricing this year
CNBC
Sat, 07/29/17 - 09:38 am
Eli Lilly
David Ricks
Pharma CEOs
drug pricing
Donald Trump
Lilly's baricitinib setback gives Pfizer's Xeljanz a clear shot at newer rivals
Fierce Pharma
Wed, 07/26/17 - 10:33 pm
Eli Lilly
baricitinib
Pfizer
Xeljanz
bloodthinners
Lilly, J&J, AbbVie and WuXi help seed a regenerative medicine upstart
Endpoints
Wed, 07/26/17 - 09:49 am
Eli Lilly
JNJ
AbbVie
WuXi
regenerative medicine
Rodeo Therapeutics
Lilly puts two-thirds of midphase cancer pipeline up for sale in major shake-up of R&D priorities
Fierce Biotech
Tue, 07/25/17 - 10:27 am
Eli Lilly
M&A
oncology
R&D
Lilly beats profit estimates, delays arthritis drug application
Yahoo/Reuters
Tue, 07/25/17 - 08:31 am
Eli Lilly
earnings
baricitinib
Torpedoed by blood clots, Eli Lilly says a baricitinib comeback in rheumatoid arthritis could take years
Endpoints
Tue, 07/25/17 - 08:27 am
baricitinib
Eli Lilly
blood clots
rheumatoid arthritis
Big Pharma Q2 Earnings Releases on Jul 25: LLY, BIIB, AMGN
Yahoo/Zacks.com
Mon, 07/24/17 - 11:14 am
earnings
Eli Lilly
Biogen
Amgen
Why Eli Lilly Expects 2Q17 Revenue Growth
Market Realist
Mon, 07/24/17 - 11:10 am
Eli Lilly
earnings
Eli Lilly offers $400M-plus deal to bag an early-stage autoimmune drug from Nektar
Endpoints
Mon, 07/24/17 - 10:46 am
Eli Lilly
autoimmune disease
NKTR-358
Nektar

Pages